Aashka Formulation Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.21 Cr
- Revenue Growth 904.46%
- Profit Growth 3.94%
- Ebitda 231.77%
- Net Worth 15.25%
- Total Assets 44.27%
About Aashka Formulation
Aashka Formulation Private Limited (AFPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2018 (Six years and nine months 13 days old ). Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹2.21 Cr.
Jigneshkumar Patel, Manishaben Patel, and Prashant Patel serve as directors at the Company.
Company Details
-
Location
Gandhi Nagar, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U36100GJ2018PTC101962
-
Company No.
101962
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Apr 2018
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Aashka Formulation?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jigneshkumar Patel
|
Director | 10-May-2023 | Current |
|
Manishaben Patel
|
Director | 20-Apr-2018 | Current |
|
Prashant Patel
|
Director | 10-Aug-2018 | Current |
Financial Performance of Aashka Formulation.
Aashka Formulation Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 904.46% increase. The company also saw a slight improvement in profitability, with a 3.94% increase in profit. The company's net worth Soared by an impressive increase of 15.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aashka Formulation?
Unlock access to Aashka Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Cureill Pharma Private LimitedJigneshkumar Patel is a mutual person
Charges (Loans)
₹22.08 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jul 2020 | Others | ₹3.58 M | Open |
| 07 Dec 2018 | Others | ₹1.85 Cr | Open |
How Many Employees Work at Aashka Formulation?
Unlock and access historical data on people associated with Aashka Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aashka Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aashka Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
